Sign in
Taking peopleNo phase

Post Market Clinical Follow up Study With the Cervical Disc Prothesis MOVE®-C

Key facts

Who runs it
NGMedical GmbH
Where
Austria and Germany7 sites in 2 countriesChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
170 people, planned
Started
11 Mar 2021
Expected to end
11 Mar 2027
Type of study
Interventional
Treatments tested
  • MOVE®-C
Record updated
15 November 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Diagnosis of discopathy or disc hernia with radiculopathy or stenosis of the foramen and spinal canal,
  • documented individual history of neck and/or upper extremity pain and/or functional/neurological deficit associated with the cervical level to be treated,
  • no surgical treatment regarding the planned index surgery within the last six weeks prior implantation,
  • unsuccessful conservative medical care regarding the indication within the last six weeks,
  • age ≥18 years,
  • patient must agree to fully participate in the clinical trial and give informed consent in writing,
  • patient is capable to realise the nature, aims and possible consequences of the clinical trial (MPG §20.2.1),
  • patient information has been provided and all written consents of the patient are available

Who cannot take part

  • Known contraindication against the use of cervical intervertebral disc prostheses in accordance with the manufacturer's instructions for use:; Bone mineral density with T-score ≤ -1.5 as determined by spine DXA if male ≥ 60 years of age or female ≥ 50 years of age,; active systemic infection or infection at the operative site,; sustained osteoporotic fracture of the spine, hip or wrist,; spinal metastases,; known allergy to titanium or polycarbonate-urethane,; confirmed pregnancy,; severe cervical myelopathy,; patients requiring a treatment that destabilises the spine (e.g. posterior element decompression),; advanced cervical anatomical deformity at the operative site (e.g. ankylosing spondylitis, scoliosis),; advanced degenerative changes (e.g. spondylosis) at the index vertebral level,; patient is kept in an institution under judicial or official orders (MPG §20.3)

This trial is currently available in Austria and Germany.

It has sites in 2 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

Study design: International, prospective, multicentre, non-randomised, observational study according to § 23b MPG.

Read full original descriptionShow less

Objectives: Observational study to confirm the safety and performance of the cervical disc prosthesis MOVE®-C.

The group in the trial

  • PMCF MOVE-CTreatment being tested

    PMCF MOVE®\_C is a single arm observational study with 170 patients.

    Treatment: MOVE®-C

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
"PMCF MOVE®-C" International, Prospective, Multicentre, Non-randomised Post-market Clinical Follow-up Study Clinical and Radiological Outcome After Mono- and Bisegmental Cervical Intervertebral Disc Prosthetics
Record updated
15 November 2024